AQY2 Antibody

What is AQY2 and what biological systems express this protein?

The variation in AQY2 structure appears to be related to sequence repeats. As noted in research findings: "Part of the 11-bp deletion corresponds to a sequence that is repeated three times in Σ1278b AQY2. Deletion and insertion of repeats in the Saccharomyces genome have been observed. Possible mechanisms for the deletion may include errors during recombination or polymerase slippage during replication" .

While AQY2 was initially characterized in yeast, related aquaporins exist across species. Commercial antibodies like AQY2 Antibody #3487 show reactivity to human, mouse, and rat specimens, suggesting conservation of related epitopes across these mammalian species .

What is the cellular localization of AQY2 protein?

The cellular localization of AQY2 varies depending on the yeast strain and can significantly impact function. In Σ1278b strain, AQY2 localizes primarily to the endoplasmic reticulum. Immunofluorescence studies show that "when aqy1 null Σ1278b cells were probed with anti-Aqy2p antibody, perinuclear staining appeared similar to staining with anti-Kar2p antibody, a marker for endoplasmic reticulum" . This ER localization pattern differs dramatically from plasma membrane proteins like Pma1p.

Interestingly, AQY2 from different yeast species shows distinct localization patterns. When AQY2 from S. chevalieri was expressed in Σ1278b aqy2 null cells, "a distinctive plasma membrane staining pattern was observed that appeared identical to the pattern that was seen when Pma1p was labeled" . This difference in localization correlates with functional differences - S. chevalieri AQY2 is functional in Xenopus oocytes, while Σ1278b AQY2 exhibits low water permeability.

These localization differences highlight the importance of strain-specific consideration when using AQY2 antibodies in research and suggest that subcellular trafficking mechanisms play a crucial role in regulating AQY2 function.

What research applications are AQY2 antibodies suitable for?

AQY2 antibodies serve as versatile tools in various research applications investigating water channel proteins. Based on available data, these antibodies are validated for:

• Western Blotting: Commercial antibodies like AQY2 Antibody #3487 are validated for Western blotting at a dilution of 1:1000, detecting endogenous AQY2 protein at approximately 26 kDa .

• Immunofluorescence microscopy: Anti-AQY2 antibodies have been successfully used for indirect immunofluorescence at dilutions of 1:100, as demonstrated in studies visualizing AQY2 localization in yeast cells .

• Comparative studies: AQY2 antibodies enable comparative analysis of wild-type and mutant strains, as well as cross-species comparisons, providing insights into functional conservation and divergence.

• Protein expression quantification: These antibodies allow researchers to measure expression levels under different environmental conditions, particularly important when studying osmotic stress responses.

• Functional characterization: When combined with knockout strains and functional assays, AQY2 antibodies help correlate protein expression with phenotypic outcomes like survival during osmotic stress.

The range of validated applications makes AQY2 antibodies valuable for researchers investigating water transport mechanisms, osmotic regulation, and the broader roles of aquaporins in cellular processes.

How should researchers validate the specificity of AQY2 antibodies?

Validating AQY2 antibody specificity is critical for reliable research outcomes, particularly given the high sequence similarity between aquaporins. For comprehensive validation, researchers should implement the following methodological approach:

• Genetic knockout controls: The most definitive validation method involves using aqy2 null cells as negative controls. Research demonstrates that "When Σ1278b cells lacking both Aqy1p and Aqy2p were stained with anti-Aqy2p, minimal background staining appeared" . This confirms the absence of non-specific binding.

• Western blot analysis: Verify that the antibody detects a protein of the expected molecular weight (approximately 26 kDa for AQY2) . Multiple bands or bands at unexpected sizes may indicate cross-reactivity.

• Peptide competition assays: Pre-incubate the antibody with the immunizing peptide (e.g., the N-terminal peptide NH2-CSNESNDLEKNISHLDPTGVDN-COOH used to generate anti-Aqy2p antibodies) . This should abolish specific binding in subsequent assays.

• Cross-reactivity assessment: Since "Aqy1p and Aqy2p are highly conserved with amino acid sequences which are 87% identical" , researchers must evaluate potential cross-reactivity between these highly similar proteins. Single knockout strains (aqy1Δ or aqy2Δ) can help determine specificity.

• Recombinant protein controls: Express recombinant AQY2 at known concentrations as positive controls for calibration and specificity confirmation.

The importance of this rigorous validation is underscored by the finding that "many antibodies that scientists purchase from commercial manufacturers to conduct their research do not work as advertised, because most have never been validated properly" . Following these validation steps will ensure reliable and reproducible research outcomes.

How does AQY2 expression affect cell morphology and phenotype?

AQY2 expression has profound effects on cell morphology and phenotype beyond its canonical role in water transport. Research reveals a surprising connection between AQY2 and cell surface properties:

• Colony morphology: "Deletion of AQY2 results in diminished fluffy colony morphology while overexpression of AQY2 causes strong agar invasion and adherence to plastic surfaces" . This suggests AQY2 influences extracellular matrix interactions and cell-surface adhesion properties.

• Environmental modulation: "Hyper-osmotic stress inhibits morphological developments including the above characteristics as well as AQY2 expression through the osmoregulatory Hog1 mitogen-activated protein kinase" . This indicates integration of environmental sensing with morphological development via AQY2.

• Expression pattern correlations: "The AQY2 expression pattern resembles in many ways that of MUC1/FLO11, which encodes a cell surface glycoprotein required for morphological developments" . This parallel expression suggests potential functional coordination.

• Osmotic stress response: When subjected to osmotic cycling (growth in high sorbitol followed by water exposure), "aqy2 null cells were less sensitive to the osmotic stress" . This demonstrates AQY2's role in modulating cellular responses to osmotic challenges.

These findings have broader implications, as "Our observations suggest a potential link between aquaporins and cell surface properties, and relate to the proposed role of mammalian aquaporins in tumour cell migration and invasion" . This connection positions AQY2 research as potentially relevant to understanding fundamental mechanisms of cell morphology regulation across species.

What signaling pathways regulate AQY2 expression?

AQY2 expression is controlled by a complex network of signaling pathways that integrate osmotic, nutritional, and morphogenic signals. Three major regulatory systems have been identified:

• The osmoregulatory Hog1 MAPK pathway:

  • "Hyper-osmotic stress inhibits morphological developments including the above characteristics as well as AQY2 expression through the osmoregulatory Hog1 mitogen-activated protein kinase" .

  • This pathway allows cells to downregulate AQY2 during high osmotic conditions, likely preventing excessive water efflux.

• The protein kinase A (PKA) pathway:

  • "The protein kinase A pathway derepresses AQY2 expression through the Sfl1 repressor" .

  • This nutrient-responsive pathway modulates AQY2 expression based on the cell's metabolic state, creating a link between metabolism and water homeostasis.

• The filamentous growth Kss1 MAPK pathway:

  • "The filamentous growth Kss1 mitogen-activated protein kinase pathway represses AQY2 expression in a Kss1 activity-independent manner" .

  • This represents an unusual regulatory mechanism where the pathway components, rather than the kinase activity itself, mediate repression.

This intricate regulation places AQY2 at the intersection of multiple cellular processes, explaining its diverse roles in both water transport and morphological development. The complex regulation also provides multiple experimental avenues for studying AQY2 expression, with potential implications for understanding aquaporin regulation in higher organisms.

How do different AQY2 variants affect water permeability?

AQY2 variants exhibit significant differences in water permeability and subcellular localization, providing valuable insights into structure-function relationships. Experimental evidence reveals distinct functional properties:

• Strain-specific functional differences:

  • "Oocytes injected with Σ1278b AQY2 cRNA exhibited low water permeabilities" , indicating limited functionality.

  • In contrast, "S. chevalieri AQY2 is functional in oocytes and traffics to the plasma membrane of yeast, whereas Σ1278b Aqy2p does not" .

• Correlation between localization and function:

  • "Indirect immunofluorescence of oocytes expressing Σ1278b Aqy2p revealed that the polypeptide did not traffic to the plasma membrane" , explaining its limited functionality.

  • The functional S. chevalieri AQY2 showed "a distinctive plasma membrane staining pattern" , supporting the connection between proper membrane localization and water channel activity.

• Impact on osmotic stress response:

  • Functional differences translate to physiological outcomes: "aqy2 null cells that expressed S. chevalieri Aqy2p were more sensitive to osmotic stress than aqy2 null cells containing vector alone" .

  • This demonstrates that water permeability mediated by functional AQY2 affects cellular responses to osmotic challenges.

These findings highlight the importance of considering strain-specific variations when studying AQY2 function. The correlation between trafficking to the plasma membrane and functional water transport activity provides a mechanistic explanation for the observed differences between variants.

What methodological approaches can distinguish between AQY1 and AQY2 in experimental systems?

Distinguishing between the highly similar aquaporins AQY1 and AQY2 presents a significant methodological challenge. Comprehensive strategies to differentiate these proteins include:

• Genetic approaches:

  • Utilize knockout strains: "indirect immunofluorescence was studied in cells expressing single aquaporin genes" . Creating aqy1Δ and aqy2Δ single and double knockout strains provides definitive systems for protein-specific analysis.

  • Complementation experiments: Reintroduce specific aquaporin genes to confirm phenotypic restoration.

• Antibody optimization:

  • Target unique epitopes: Despite 87% sequence identity, strategic antibody design targeting divergent regions can improve specificity.

  • Address cross-reactivity challenges: "Although Aqy1p and Aqy2p differ at 8 of 21 N-terminal residues, antibodies raised to the N-terminal peptides yield significant cross-reactivity" . This necessitates careful validation and control experiments.

• Immunoprecipitation followed by mass spectrometry:

  • This approach can identify unique peptides that definitively distinguish between AQY1 and AQY2.

  • Advanced mass spectrometry techniques like selected reaction monitoring can quantify specific aquaporin isoforms.

• Functional assays:

  • Exploit differential phenotypes: Research shows that both AQY1 and AQY2 affect osmotic stress sensitivity, but potentially through different mechanisms.

  • Compare knockout phenotypes: "When aqy1 null cells were compared side-by-side with aqy2 null cells, no difference in survival was observed during the osmotic cycles" , but combined with other assays, functional differences may emerge.

• Localization studies:

  • Subcellular distribution differences: Different trafficking patterns or compartmentalization between AQY1 and AQY2 can aid differentiation.

This multi-faceted approach provides researchers with a robust methodology to distinguish between these highly similar but functionally distinct aquaporins.

How can researchers apply biophysics-informed modeling to engineer AQY2 antibodies with customized specificity?

Recent advances in computational antibody engineering offer powerful approaches for developing AQY2 antibodies with enhanced specificity profiles. Drawing from research on antibody-antigen interactions, researchers can apply biophysics-informed modeling strategies:

• Binding mode identification and analysis:

  • "Our biophysics-informed model is trained on a set of experimentally selected antibodies and associates to each potential ligand a distinct binding mode, which enables the prediction and generation of specific variants beyond those observed in the experiments" .

  • For AQY2 antibodies, this approach can identify distinct binding modes that differentiate between AQY2 and closely related aquaporins like AQY1.

• Energy function optimization for specificity engineering:

  • "The generation of new sequences relies on optimizing over s the energy functions E associated with each mode sw w" .

  • "To obtain cross-specific sequences, we jointly minimize the functions E associated with the desired ligand. On the contrary, to obtain specific sequences, we minimize sw E associated with the desired ligand sw w and maximize the ones associated with undesired ligands" .

  • This mathematical framework allows rational design of antibodies that specifically target AQY2 while avoiding cross-reactivity with AQY1.

• Experimental validation through phage display:

  • "We conducted a series of phage display experiments involving antibody selection against diverse combinations of closely related ligands" .

  • Similar approaches can validate computationally designed AQY2 antibodies.

• Generation of novel antibody sequences:

  • "Our model can be employed to design novel antibody sequences with predefined binding profiles. These profiles can be either cross-specific, allowing interaction with several distinct ligands, or specific, enabling interaction with a single ligand while excluding others" .

  • This enables creation of AQY2 antibodies with precise specificity profiles - either highly specific for a single AQY2 variant or intentionally cross-reactive across multiple aquaporins.

This computational approach represents a significant advance over traditional antibody development methods: "Our approach involves the identification of different binding modes, each associated with a particular ligand against which the antibodies are either selected or not" . The combination of biophysical modeling with experimental validation provides a powerful framework for developing next-generation AQY2 antibodies with unprecedented specificity control.

What are the optimal immunofluorescence protocols for AQY2 detection?

Optimizing immunofluorescence protocols for AQY2 detection requires careful attention to sample preparation, antibody parameters, and imaging conditions. Based on published methodologies, the following protocol optimizations are recommended:

• Cell preparation and fixation:

  • For yeast studies: "Yeast were grown overnight in uracil-deficient medium and then diluted in YPGal (1% yeast extract/2% peptone/2% galactose) and incubated overnight to induce expression" .

  • Ensure fixation methods preserve antigen accessibility while maintaining cellular architecture.

• Antibody selection and dilution:

  • Primary antibody: "Anti-Aqy2p polyclonal antiserum to a synthetic peptide from the N terminus (NH2-CSNESNDLEKNISHLDPTGVDN-COOH) was raised in rabbits and affinity purified by using a SulfoLink column" .

  • Optimal dilutions: "Anti-Aqy2p antibody was used at a dilution of 1:100, and the secondary antibody Alexa 488 conjugated goat anti-rabbit was used at 1:400" .

• Co-staining with subcellular markers:

  • ER marker: "Anti-Kar2p antibody was used at a 1:5000 dilution" .

  • Plasma membrane marker: "Anti-Pma1p antibodies were used at a dilution of 1:100" .

  • These markers are essential for determining AQY2 subcellular localization.

• Mounting and imaging:

  • Anti-fade mounting media: "50% glycerol, 50% PBS with 10 mg/ml DABCO (1,4-diazabicyclo[2.2.2]octane) and 50 ng/ml of DAPI (4′6,-diamidino-2-phenylindole)" .

  • High-resolution imaging: "Cells were photographed by using the ×100 objective of a Zeiss Axioplan 2 fluorescence microscope" .

• Controls for specific detection:

  • Negative control: "When Σ1278b cells lacking both Aqy1p and Aqy2p were stained with anti-Aqy2p, minimal background staining appeared" .

  • Positive control: Cells overexpressing AQY2 to confirm antibody functionality.

By carefully implementing these protocol optimizations, researchers can achieve specific detection of AQY2 with minimal background and cross-reactivity. The inclusion of appropriate subcellular markers further enhances the information gained, allowing precise determination of AQY2 localization patterns.

What experimental setup is needed to study AQY2's role in osmotic stress responses?

Investigating AQY2's role in osmotic stress responses requires a comprehensive experimental framework combining genetic manipulation, stress application, and phenotypic assessment. Based on published methodologies, an optimal experimental setup includes:

• Strain preparation and genetic manipulation:

  • Create appropriate genetic backgrounds: Wild-type, aqy2Δ, aqy1Δ, and aqy1Δ-aqy2Δ double mutants as described: "JC0123 (MATa aqy1Δ∷loxP-kanMX-loxP aqy2Δ∷loxP-kanMX-loxP trp1Δ1)" .

  • Complementation vectors: Transform null strains with plasmids expressing wild-type or variant AQY2 genes.

• Osmotic stress application protocol:

  • Growth under high osmolarity: "Parent strain Σ1278b and aqy2 null cells were grown in YPD + 1.7 M sorbitol" .

  • Hypoosmotic shock: "washed in H2O" .

  • This osmotic cycling effectively reveals AQY2-dependent phenotypes.

• Survival and phenotypic assessment:

  • Quantify survival rates: Compare wild-type, knockout, and complemented strains following osmotic cycling.

  • Document morphological changes: Colony appearance, invasion properties, and cell aggregation.

• Protein expression and localization analysis:

  • Monitor AQY2 levels during stress: Western blotting with AQY2 antibodies at different timepoints during osmotic challenge.

  • Track subcellular redistribution: Immunofluorescence before and after osmotic shifts to detect potential relocalization.

• Pathway inhibition experiments:

  • Target regulatory kinases: Since "Hyper-osmotic stress inhibits morphological developments including the above characteristics as well as AQY2 expression through the osmoregulatory Hog1 mitogen-activated protein kinase" , Hog1 inhibition experiments can reveal regulatory mechanisms.

  • Assess PKA and Kss1 MAPK pathway contributions to AQY2 regulation during stress.

This comprehensive experimental framework enables detailed characterization of AQY2's functions during osmotic challenges. Key findings from previous studies revealed that "aqy2 null cells were less sensitive to the osmotic stress" and "aqy2 null cells that expressed S. chevalieri Aqy2p were more sensitive to osmotic stress than aqy2 null cells containing vector alone" , highlighting the importance of this methodological approach in understanding AQY2 biology.

How can researchers detect and quantify post-translational modifications of AQY2?

Post-translational modifications (PTMs) of AQY2 likely play critical roles in regulating its function, localization, and stability. To comprehensively detect and quantify these modifications, researchers should implement the following methodological approaches:

• Mass spectrometry-based PTM mapping:

  • Sample preparation: Immunoprecipitate AQY2 from cell lysates using validated antibodies.

  • Digestion strategies: Use multiple proteases (trypsin, chymotrypsin, Glu-C) to ensure complete sequence coverage.

  • Enrichment techniques: For phosphorylation, employ titanium dioxide (TiO2) or immobilized metal affinity chromatography (IMAC); for glycosylation, use lectin affinity or hydrazide chemistry.

  • LC-MS/MS analysis: Perform high-resolution mass spectrometry with fragmentation methods optimized for PTM detection (HCD, ETD).

• Site-specific modification antibodies:

  • Develop antibodies targeting specific modified epitopes (e.g., phospho-specific antibodies).

  • Use these in Western blotting to monitor changes in modification status under different conditions.

• Mobility shift assays:

  • Phosphorylation often causes mobility shifts in SDS-PAGE.

  • Compare migration patterns before and after phosphatase treatment to identify phosphorylated forms.

• Fluorescent labeling of glycans:

  • If AQY2 is glycosylated, use fluorescent labeling strategies to detect and quantify glycan structures.

  • Perform lectin blotting to identify specific glycan structures.

• Targeted quantification of modified peptides:

  • Implement parallel reaction monitoring (PRM) or selected reaction monitoring (SRM) for absolute quantification of modified peptides.

  • Use stable isotope-labeled synthetic peptides as internal standards for accurate quantification.

• PTM dynamics during stress:

  • Monitor changes in AQY2 modifications during osmotic stress and other environmental challenges.

  • Correlate modification patterns with protein localization and function.

When applying these methods, consider the following experimental design principles for rigorous PTM analysis:

• Include appropriate controls (phosphatase-treated, deglycosylated samples)

• Analyze biological replicates to assess reproducibility

• Implement quantitative approaches to measure stoichiometry of modifications

• Correlate PTM data with functional assays to establish biological significance

By implementing these approaches, researchers can generate comprehensive PTM maps of AQY2 and investigate how these modifications regulate aquaporin function in response to changing cellular conditions.

What are the best approaches for high-throughput screening of AQY2 antibodies?

Recent methodological advances enable efficient high-throughput screening of antibodies, including those targeting AQY2. Implementing these approaches can accelerate antibody discovery while reducing resource requirements:

• Multiplexed antibody testing in animal models:

  • "Researchers at UZH have now developed a technology that can be used to test around 25 antibodies simultaneously in a single mouse" .

  • This approach drastically reduces animal usage: "The approach we developed allows us to test 25 different antibodies simultaneously in a single mouse. This speeds up the process and reduces the number of animals required" .

  • Implementation requires molecular barcoding: "To allow individual analysis of the properties of the antibodies from the complex plasma or tissues samples from the mice, the researchers developed a form of barcodes. They are made up of defined protein fragments – known as flycodes – that can be used to mark each antibody individually" .

• Validation through CRISPR knockout controls:

  • "The science on the optimal antibody testing methodology is largely settled: using an appropriately selected wild type human cell and a CRISPR knockout version of the same cell as the basis for testing yields the most rigorous and broadly applicable results" .

  • This gold-standard approach provides definitive specificity validation.

• Independent third-party testing:

  • Projects like YCharOS conduct "independent, third-party testing of commercial antibody manufacturers' catalogs and publish the results in the public domain, such that no scientist ever uses an ineffective antibody again" .

  • Similar approaches can be applied to newly developed AQY2 antibodies.

• Phage display with biophysics-informed modeling:

  • "We conducted a series of phage display experiments involving antibody selection against diverse combinations of closely related ligands" .

  • This approach enables both discovery and specificity engineering: "Our model's predictive power by using data from one ligand combination to predict outcomes for another" .

• On-demand antibody development:

  • Emerging predictive approaches may enable faster development: "In the future, it may enable on-demand development of antibody-based drugs, just as Netflix enabled on-demand TV series: we may no longer have to wait until next season to get our antibodies or vaccines" .

The high-throughput screening data should be systematically analyzed and documented:

By implementing these advanced screening methodologies, researchers can efficiently develop and validate high-quality AQY2 antibodies while minimizing resource utilization and experimental bias.